IOPtima
Surgical Ophthalmic Laser Devices and Accessories
Startup Acquired Health Tech & Life Sciences Est. 2005 Acquired
🌐 WebsiteLinkedInTwitter
Total Raised
$7.2M
Acquired
Last Round
$7.2M
1 rounds
Investors
3
3 public
Team
3
1-10 employees
Confidence
100/100
News
9
articles
Patents
1
About
IOPtima is a rapidly growing company focused on developing minimally invasive and innovative surgical ophthalmic devices. Its flagship product, the IOPtimate, is a surgical system for the treatment of glaucoma that utilizes CO2 laser technology to significantly reduce internal eye pressure without penetrating the eye. The company also offers a line of patented eye drops to treat ocular surface diseases. IOPtima is a Kanghong Pharmaceutical company.
Classification
Sector
Health Tech & Life SciencesMedical DevicesMedical Treatment & TherapeuticsPharma & Medical BiotechnologyDrugs Discovery & Development
Core Technology
SensingLaser
Target Customer
Healthcare & Life SciencesHealthcareProvidersLife SciencesPharmaceuticals
Business Model
B2B
Tags
medical-deviceseye-diseasesminimally-invasivesurgerylasersglaucomaophthalmologyhospitalspharma-companiesclinicshealthcare-providersmedical-technologiesoptronics
Funding & Events
Sep 2018
Exit $56M
Nov 2015
B Round $7.2M
Infinity China, Diamond Bio Fund , BIOLIGHT Life Sciences
News (9)
Sep 27, 2018 · www.calcalistech.com
growth-positive
Chengdu Kanghong Pharma Solidifies Ownership of Israeli Medical Device Company
InvestmentAcquisition
Nov 21, 2017 · en.globes.co.il
growth-positive
Chengdu Kanghong Pharma buys Israel's IOPtima for $56m
AcquisitionInvestment
Oct 2, 2017 · www.healio.com
growth-positive
IOPtima launches Lipitear phospholipid microemulsion
Customers
Jul 12, 2017 · www.healio.com
growth-positive
IOPtima launches iLid CO2 laser kit for blepharoplasty
Customers
Apr 19, 2017 · www.globes.co.il
growth-positive
BioLight to sell IOPtima to Chinese co
AcquisitionInvestment
Dec 21, 2015 · www.prnewswire.com
growth-positive
Bio Light's IOPtiMate[TM] System Receives Regulatory Approval in Canada
CustomersPartnersInvestment
Mar 11, 2014 · www.asianscientist.com
growth-positive
BioLight Eyes Chinese Glaucoma Market, Raises US$5.5 Million - Asian Scientist Magazine
Investment
Nov 16, 2009 · www.bioopticsworld.com
N/A
https://www.bioopticsworld.com/articles/2009/11/ioptima-receives-europea-patent-approval-for-laser-system-for-treatment-of-glaucoma.html
Sep 21, 2007 · www.israel21c.org
growth-positive
Israel's IOPtima shines a light at the end of the glaucoma tunnel
Customers
Details
Product Stage
Released
Employees
1-10
Exact Count
8
District
Center District
Founded
2005
Registrar
513264424
Crunchbase
ioptima
Locations
Leshem St 10, Caesarea, Israel
Links
Website
www.ioptima.com
LinkedIn
Profile
Twitter
Profile
Admin
Last Update
Sep 7, 2024
Verified by
Sharon Shapira
Claimed
Yes
Missing
markets
Team (3)
Ronen Castro
CEO
Eran Kaplan
VP R&D
Yaron Sfadyah
Director of Business Development
Internal
Created by
Tamar Weiss (tamar.e.weiss@gmail.com)
Created
2014-07-21T00:00:00.000Z
Last editor
Orli Wollner (orlushka@gmail.com)
Status
Acquired by Chengdu Kanghong Pharmaceutical Group on Sep, 2018
Finder · IOPtima · 2026